medigraphic.com
SPANISH

Acta Médica Grupo Angeles

Órgano Oficial del Hospital Angeles Health System
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
    • Names and affiliations of the Editorial Board
  • Policies
  • About us
    • Data sharing policy
    • Stated aims and scope
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2008, Number 4

<< Back Next >>

Acta Med 2008; 6 (4)

Current treatment of larynx cancer

Gallegos HJF
Full text How to cite this article

Language: Spanish
References: 12
Page: 154-157
PDF size: 59.15 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. TNM Staging system for the larynx. American Joint Committee on Cancer (AJCC) 2002.

  2. Carew JF. The larynx: Advances stage disease. In: Shah JP. Editor Cancer of the head and neck. Hamilton. BC Decker Inc.; 2001: 156-69.

  3. Gallegos HJF, Martínez GH, Flores R. La disección radical de cuello en cáncer de vías aerodigestivas superiores (VADS). Indicaciones, extensión y radicalidad. Cir Ciruj 2002; 70: 369-76.

  4. Cortes-Arroyo H, Rodríguez-Cuevas S, Labastida-Almendaro S. Quality control in planning and technique of radiotherapy with cobalto-60 for T1 glottic cancer increase local control and organ preservation. Am J Surg 1997; 174: 477-80.

  5. Gallegos-Hernández JF, Minauro-Muñoz G, Arias-Ceballos H, Hernández-Sanjuan M, Flores-Díaz R, Reséndiz-Colosia J. Partial pharyngolaryngectomies for treatment of pharyngolaryngeal cancer. Cir Cir 2008; 76: 209-13.

  6. Lefebvre JL. Surgical aspects in head and neck cancer. Ann Oncol 2005; 16 Suppl 2ii: 251-4.

  7. American Society of Clinical Oncology, Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK, Clayman GL, Fisher SG, Forastiere AA, Harrison LB, Lefebvre JL, Leupold N, List MA, O’Malley BO, Patel S, Posner MR, Schwartz MA, Wolf GT. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006; 24(22): 3693-704.

  8. Fuentes A, Gallegos HJF, Minauro MG, Reséndiz CJA, Flores-DR, Arias CH et al. Arytenoid mobility as a risk factor for lymph node metastasis in laryngeal cancer. 7th International Conference on Head and Neck Cancer, 2008. San Francisco, Ca. Abstract: P-595.

  9. Gallegos HJF, Minauro MG, Hernández HDM, Flores CA, Hernández SJM, Reséndiz CJA. Tiroidectomía asociada a laringectomía en el tratamiento del cáncer laríngeo. ¿Es necesario efectuarla rutinariamente? Cir Cir 2005; 73: 3-6.

  10. Pelliteri PK, Ferlito A, Rinaldo A, Shah JP, Weber RS, Lowry J et al. Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? Head and Neck 2006; 28: 166-75.

  11. Lefebvre JL. Laryngeal preservation in head and neck cancer: multidisciplinary approach. Lancet Oncol 2006; 7: 747-55.

  12. Adelstein DJ, Rodríguez CP. Current and emerging standards of concomitant chemoradiotherapy. Semin Oncol 2008; 35: 211-20.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Med. 2008;6